(Date:5/15/2008)...ombining natural organic atoms with metal complexe...ed a new type of enzyme inhibitor capable of block... cancer development. , Based on studies in huma...eveloping new ways to treat cancer by dampening th...olled tumor growth. , Details of the study, to b...
(Date:5/15/2008)...ay 15 /PRNewswire-FirstCall/ -- Lung cancer patien...sions may fare better as a,result, according to da...C),clinical trial. Data from the trial, which invo... for injection), will be presented at the 44th Ann...cology (ASCO) in Chicago,Ill., May 30 -- June 3, ...
(Date:5/15/2008)...ity-control audit of community hospitals associate...gests that a partnership between a major academic ...are created, and community hospitals, where most c...uickly and effectively disseminating advances in c...d Comprehensive Cancer Center in Philadelphia, fir...
(Date:5/15/2008)...motherapy given in conjunction with cancer vaccine...ly improving the effectiveness of this promising t...earchers in the Duke Comprehensive Cancer Center. ...ls that suppress immune function and we speculated...used in conjunction with vaccines, which work by b...
Breaking Medicine News(10 mins):Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Chemotherapy might help cancer vaccines work 2... Agreement with Laboratoire Physcience, France, fo...ibra(R)//, as a single dose mini-shot, in France, ...ssfully launched its Slim 10/10 product into these... successful ever product launch into the French ma...
...ering from symptoms of hypertension in the young d...consequences// of hypertension as they become adul... and found that prehypertension leads to hypertens...alkner, MD, professor of medicine and pediatrics a...
...lled antisense drugs, which can block the genes as...til now, it has been difficult for scientists to f...vented from breaking down before they reach the ta...e overcome by combining the drugs with small gold ...
...r more drugs made by a Heilongjiang Province drug ...ed with a poisonous industrial chemical. // It w...cal hospital in Guangzhou, capital city of south's... have shown symptoms of acute renal failure after ...
Other Medicine News:Health News:Prehypertension in the Young Leads to Hypertensive Adults 2Health News:Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight 2Health News:Investigators Find Poisonous Chemicals In Four More Drugs In China 2(Date:5/14/2008)... with Scripps Florida and Scripps Research in La ...FRANCISCO, Calif., and LA JOLLA, Calif., May 14 /P...Inc. (Nasdaq: PARD ), a,biopharmaceutical company...titute, a non-profit biomedical research organizat...ecuted licensing classes of protein kinase,inhibit...
(Date:5/14/2008)...innovations advocate to lead expansion of Cytel,s ... business, CAMBRIDGE, Mass., May 14 /PRNewswire/ ...l design services and specialized statistical soft...inlan as Vice President,Adaptive Trials., Judith...xperience to,the Cytel team. Prior to joining Cyte...
(Date:5/14/2008)...4 /- The Quigley,Corporatio... a study,conducted by its wholly owned subsidiary,...ens to evaluate the anti-viral activity of its com...hicks that had been infected,with Infectious Bronc...ed,that QR448(a) is efficacious against an IBV cha...
(Date:5/13/2008)...PRNewswire-USNewswire/ -- In women at increased,ri...d examination to,routine mammography revealed 28 p...r, the additional ultrasound exam substantially in...nnecessary biopsies, according to an,American Coll...lished in,the May 14, 2008 issue of the Journal of...
Breaking Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Judith Quinlan Joins Cytel as Vice President, Adaptive Trials 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 2Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 3Why do autumn leaves bother to turn red 3F 969 1Why do autumn leaves bother to turn red 3F 969 2Research sheds new light on how diseases jump across species 968 1Research sheds new light on how diseases jump across species 968 2ZONARE Names Marcotte Chief Financial Officer 4588 1ZONARE Names Marcotte Chief Financial Officer 4588 2SafeHands School Program to Help Fight Spread of MRSA Staph Virus 4583 1SafeHands School Program to Help Fight Spread of MRSA Staph Virus 4583 2...GE, Mass.--(BUSINESS WIRE)--Jun 6, 2007 - Combinat...that data from its,randomized, blinded, placebo-co...ients with osteoarthritis (OA) and rheumatoid,arth... against,Rheumatism (EULAR) Annual Congress of Rhe...Spain., Schedule of Events: , -- Satellite Symposi...
...33 reduces esophageal reflux - , Waltham, Mass., J...reported positive results of its randomized, doubl...33 for gastroesophageal,reflux disease (GERD). Th...pt for DDP733 as a treatment for nocturnal GERD,(N...tical,significance over placebo on the primary end...
Other Medicine Technology:Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting 2Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting 3Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption.
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers.
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis.
Lyphochek Immunoassay Plus Control provides the clinical laboratory with the most comprehensive control in the world for monitoring immunoassay and therapeutic drug monitoring procedures, eliminating
Medicine Products: